Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Vanguard Ultra Short Bond ETF (VUSB) Price & Performance

AbCellera Biologics IncTrade
Vanguard Ultra Short Bond ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Vanguard Ultra Short Bond ETF — how do they compare? AbCellera Biologics Inc trades at $9.05 (market cap $2.99B), while Vanguard Ultra Short Bond ETF trades at $49.67. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, Vanguard Ultra Short Bond ETF nearer its low. Which is the better fit depends on your goals.

ABCLVUSB
Market Cap
$2.99B
Sector
HealthLeveraged / Inverse
52-Week High
$9.76$50.03
52-Week Low
$2.78$49.60
Enterprise Value
$2.58B

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Vanguard Ultra Short Bond ETF

VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.

Read more on VUSB